$KZR.US – ranked positive on March 23rd, 2022
Kezar Life Sciences – (KZR, +N, 23-Mar-22) Franklin Berger (Non-Executive since 2016) purchased $1.3 million of stock at $16.25 on March 21st, increasing his holding by 10%. This is his first open-market purchase and its size is larger than his two previous subscriptions combined in February and June 2020 at $2.60 and $5.50 respectively. He […]